Longitudinal Analysis Is More Powerful than Cross-Sectional Analysis in Detecting Genetic Association with Neuroimaging Phenotypes

Most existing genome-wide association analyses are cross-sectional, utilizing only phenotypic data at a single time point, e.g. baseline. On the other hand, longitudinal studies, such as Alzheimer's Disease Neuroimaging Initiative (ADNI), collect phenotypic information at multiple time points. In this article, as a case study, we conducted both longitudinal and cross-sectional analyses of the ADNI data with several brain imaging (not clinical diagnosis) phenotypes, demonstrating the power gains of longitudinal analysis over cross-sectional analysis. Specifically, we scanned genome-wide single nucleotide polymorphisms (SNPs) with 56 brain-wide imaging phenotypes processed by FreeSurfer on 638 subjects. At the genome-wide significance level () or a less stringent level (e.g. ), longitudinal analysis of the phenotypic data from the baseline to month 48 identified more SNP-phenotype associations than cross-sectional analysis of only the baseline data. In particular, at the genome-wide significance level, both SNP rs429358 in gene APOE and SNP rs2075650 in gene TOMM40 were confirmed to be associated with various imaging phenotypes in multiple regions of interests (ROIs) by both analyses, though longitudinal analysis detected more regional phenotypes associated with the two SNPs and indicated another significant SNP rs439401 in gene APOE. In light of the power advantage of longitudinal analysis, we advocate its use in current and future longitudinal neuroimaging studies.

[1]  Yun Liu,et al.  Effects of genetic variants on lipid parameters and dyslipidemia in a Chinese population[S] , 2011, Journal of Lipid Research.

[2]  Michael Weiner,et al.  Voxelwise gene-wide association study (vGeneWAS): Multivariate gene-based association testing in 731 elderly subjects , 2011, NeuroImage.

[3]  Xihong Lin,et al.  Rare-variant association testing for sequencing data with the sequence kernel association test. , 2011, American journal of human genetics.

[4]  T. Hansen,et al.  Associations between APOE Variants and Metabolic Traits and the Impact of Psychological Stress , 2011, PloS one.

[5]  Yuanjia Wang,et al.  Longitudinal Association Analysis of Quantitative Traits , 2012, Genetic epidemiology.

[6]  A M Dale,et al.  Measuring the thickness of the human cerebral cortex from magnetic resonance images. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  D. Stram,et al.  Variance components testing in the longitudinal mixed effects model. , 1994, Biometrics.

[8]  Michael Weiner,et al.  Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort , 2010, NeuroImage.

[9]  C. Jack,et al.  Ways toward an early diagnosis in Alzheimer’s disease: The Alzheimer’s Disease Neuroimaging Initiative (ADNI) , 2005, Alzheimer's & Dementia.

[10]  A. Roses,et al.  Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. , 1994, The Journal of clinical investigation.

[11]  Hongzhe Li,et al.  Sample size and power analysis for sparse signal recovery in genome-wide association studies. , 2011, Biometrika.

[12]  Wei Pan,et al.  Asymptotic tests of association with multiple SNPs in linkage disequilibrium , 2009, Genetic epidemiology.

[13]  K S Benke,et al.  Strategy to Control Type I Error Increases Power to Identify Genetic Variation Using the Full Biological Trajectory , 2013, Genetic epidemiology.

[14]  Mary J. Malloy,et al.  Analysis of 17,576 Potentially Functional SNPs in Three Case–Control Studies of Myocardial Infarction , 2008, PloS one.

[15]  Marisa O. Hollinshead,et al.  Identification of common variants associated with human hippocampal and intracranial volumes , 2012, Nature Genetics.

[16]  Wei Pan,et al.  Comparison of statistical tests for disease association with rare variants , 2011, Genetic epidemiology.

[17]  Jung-Ying Tzeng,et al.  Haplotype-based association analysis via variance-components score test. , 2007, American journal of human genetics.

[18]  Paul M. Thompson,et al.  Identification of gene pathways implicated in Alzheimer's disease using longitudinal imaging phenotypes with sparse regression☆ , 2012, NeuroImage.

[19]  Eden R Martin,et al.  Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. , 2009, American journal of human genetics.

[20]  Wei Chen,et al.  Longitudinal Genome-Wide Association of Cardiovascular Disease Risk Factors in the Bogalusa Heart Study , 2010, PLoS genetics.

[21]  Zhi Wei,et al.  An empirical Bayes testing procedure for detecting variants in analysis of next generation sequencing data , 2013, 1401.2278.

[22]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[23]  N. Schork,et al.  Longitudinal Replication Studies of GWAS Risk SNPs Influencing Body Mass Index over the Course of Childhood and Adulthood , 2012, PloS one.

[24]  S. Zeger,et al.  Longitudinal data analysis using generalized linear models , 1986 .

[25]  Modeling Age×Major Gene Interaction by a Variance Component Approach , 2001, Genetic epidemiology.

[26]  Li Hsu,et al.  An exponential combination procedure for set-based association tests in sequencing studies. , 2012, American journal of human genetics.

[27]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[28]  Nick C Fox,et al.  The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods , 2008, Journal of magnetic resonance imaging : JMRI.

[29]  A. Dale,et al.  Subregional neuroanatomical change as a biomarker for Alzheimer's disease , 2009, Proceedings of the National Academy of Sciences.

[30]  M. Costanza,et al.  Consistency between cross-sectional and longitudinal SNP: blood lipid associations , 2012, European Journal of Epidemiology.

[31]  Claudia Hemmelmann,et al.  Statistical analysis of rare sequence variants: an overview of collapsing methods , 2011, Genetic epidemiology.

[32]  Steven Wiltshire,et al.  Impact of the Reelin signaling cascade (Ligands–Receptors–Adaptor Complex) on cognition in schizophrenia , 2012, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[33]  M. Pericak-Vance,et al.  Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[34]  K. Lunetta,et al.  Multiple loci influencing hippocampal degeneration identified by genome scan , 2012, Annals of neurology.

[35]  Momiao Xiong,et al.  Functional Linear Models for Association Analysis of Quantitative Traits , 2013, Genetic epidemiology.

[36]  Andrew J. Saykin,et al.  Hippocampal Atrophy as a Quantitative Trait in a Genome-Wide Association Study Identifying Novel Susceptibility Genes for Alzheimer's Disease , 2009, PloS one.

[37]  Momiao Xiong,et al.  Association studies for next-generation sequencing. , 2011, Genome research.

[38]  Michael W. Weiner,et al.  Discovery and Replication of Gene Influences on Brain Structure Using LASSO Regression , 2012, Front. Neurosci..

[39]  C. Kastner,et al.  The Generalised Estimating Equations: An Annotated Bibliography , 1998 .

[40]  M. Rieder,et al.  Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. , 2012, American journal of human genetics.

[41]  M. Lindquist.  The Statistical Analysis of fMRI Data. , 2008, 0906.3662.

[42]  Shannon L. Risacher,et al.  From phenotype to genotype: an association study of longitudinal phenotypic markers to Alzheimer's disease relevant SNPs , 2012, Bioinform..

[43]  Sven Cichon,et al.  A genome-wide association study for late-onset Alzheimer's disease using DNA pooling , 2008, BMC Medical Genomics.

[44]  Michael Weiner,et al.  Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease , 2010, NeuroImage.

[45]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[46]  Anindya Roy,et al.  Principal interactions analysis for repeated measures data: application to gene-gene and gene-environment interactions. , 2012, Statistics in medicine.

[47]  K. Roeder,et al.  Genomic Control for Association Studies , 1999, Biometrics.

[48]  N. Schork,et al.  Generalized genomic distance-based regression methodology for multilocus association analysis. , 2006, American journal of human genetics.

[49]  Albert Hofman,et al.  Fast linear mixed model computations for genome‐wide association studies with longitudinal data , 2013, Statistics in medicine.

[50]  Andrew J. Saykin,et al.  Voxelwise genome-wide association study (vGWAS) , 2010, NeuroImage.

[51]  Bruce Fischl,et al.  Within-subject template estimation for unbiased longitudinal image analysis , 2012, NeuroImage.

[52]  Paul M. Thompson,et al.  Increasing power for voxel-wise genome-wide association studies: The random field theory, least square kernel machines and fast permutation procedures , 2012, NeuroImage.

[53]  Mingyao Li,et al.  U‐Statistics‐based Tests for Multiple Genes in Genetic Association Studies , 2008, Annals of human genetics.